ISRCTN96827601已完成不适用
Ketoacidosis in type 2 diabetics on SGLT-2 inhibitors: a prospective observational cohort study
Southend University Hospital NHS Foundation Trust0 个研究点目标入组 60 人开始时间: 2016年9月12日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 性别
- All
入选标准
- •1. Patients with type 2 diabetes taking SGLT2i
- •2. Age > 18
- •3. Able to give consent
排除标准
- •Participants that do not meet inclusion criteria
研究者
相似试验
已完成
4 期
SGLT2 Inhibition in Patients With Type 2 Diabetes Mellitus and Acute Decompensated Heart Failure: SLIM-AHF StudyJPRN-UMIN000026315Osaka General Medical Center250
招募中
1 期
SGLTi, Hepatic Glucose Production and KetogenesisType 2 DiabetesNCT05960656The University of Texas Health Science Center at San Antonio30
已完成
不适用
Effects of sodium-glucose co-transporter 2 inhibitor on metabolic parameters in patients with diabetes mellitusType 2 diabetesJPRN-UMIN000021584agoya University150
招募中
不适用
Effects of a SGLT2 Inhibitor in type 2 Diabetes Mellitustype 2 Diabetes MellitusJPRN-UMIN000017461ephrology, endocrinology and vascular medicine at Tohoku University Hospital60
招募中
3 期
Empagliflozin in stage 4 non-diabetic kidney diseaseChronic kidney diseaseACTRN12622001371785niversity of Otago6